AdaptHealth Corp.
General ticker "AHCO" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $1.4B (TTM average)
AdaptHealth Corp. does not follow the US Stock Market performance with the rate: -29.7%.
Estimated limits based on current volatility of 2.3%: low 6.16$, high 6.46$
Factors to consider:
- Total employees count: 10900 (+3.8%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Supplier dependency, Supply chain disruptions, Labor/talent shortage/retention, Cybersecurity threats, Acquisition/divestiture risks
- Current price 22.6% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [7.78$, 14.16$]
- 2026-12-31 to 2027-12-31 estimated range: [7.93$, 14.49$]
Financial Metrics affecting the AHCO estimates:
- Positive: with PPE of 19.9 at the end of fiscal year the price was neutral
- Positive: Operating cash flow per share per price, % of 43.81 > 24.19
- Positive: 0.56 < Operating profit margin, % of 2.77
- Positive: Inventory ratio change, % of -0.73 <= -0.37
- Positive: -7.72 < Return on assets ratio (scaled to [-100,100]) of -1.51
- Positive: 34.41 < Shareholder equity ratio, % of 35.18 <= 42.26
- Negative: Investing cash flow per share per price, % of -22.07 <= -18.95
- Negative: negative Industry operating cash flow (median)
- Negative: Industry earnings per price (median), % of -3.46 <= 0
Short-term AHCO quotes
Long-term AHCO plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $3,200.18MM | $3,260.97MM | $3,277.46MM |
| Operating Expenses | $3,798.58MM | $2,997.24MM | $3,186.59MM |
| Operating Income | $-598.40MM | $263.73MM | $90.87MM |
| Non-Operating Income | $-125.38MM | $-127.71MM | $-106.03MM |
| Interest Expense | $130.30MM | $126.67MM | $105.75MM |
| Income(Loss) | $-723.78MM | $136.02MM | $-15.15MM |
| Taxes | $-49.00MM | $41.24MM | $50.88MM |
| Net Income(Loss)* | $-678.89MM | $90.42MM | $-70.79MM |
| Stockholders Equity | $1,458.45MM | $1,571.14MM | $1,518.56MM |
| Assets | $4,508.65MM | $4,486.95MM | $4,316.58MM |
| Operating Cash Flow | $480.67MM | $541.84MM | $601.77MM |
| Capital expenditure | $337.46MM | $306.06MM | $382.39MM |
| Investing Cash Flow | $-357.28MM | $-310.27MM | $-303.19MM |
| Financing Cash Flow | $-92.53MM | $-198.95MM | $-302.19MM |
| Earnings Per Share** | $-5.06 | $0.68 | $-0.52 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.